Cargando…

GCT-71. SIOP STRATEGY TREATMENT FOR CENTRAL NERVOUS SYSTEM GERM CELL TUMORS IN A MIDDLE INCOME COUNTRY

BACKGROUND/OBJECTIVES: Central nervous system (CNS) germ cell tumors (GCTs) represent 3% of primary paediatric brain tumours in occident. They can be divided into major groups including germinomas and nongerminomatous GCTs (NGGCTs). The aim is to describe demographic characteristics, Event Free Surv...

Descripción completa

Detalles Bibliográficos
Autores principales: Oller, Agustina, Sampor, Claudia, Baroni, Lorena, Freytes, Candela, Ponce, Nicolas Fernandez, Villanueva, Gabriela, Alderete, Daniel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7715554/
http://dx.doi.org/10.1093/neuonc/noaa222.287
_version_ 1783618982581895168
author Oller, Agustina
Sampor, Claudia
Baroni, Lorena
Freytes, Candela
Ponce, Nicolas Fernandez
Villanueva, Gabriela
Alderete, Daniel
author_facet Oller, Agustina
Sampor, Claudia
Baroni, Lorena
Freytes, Candela
Ponce, Nicolas Fernandez
Villanueva, Gabriela
Alderete, Daniel
author_sort Oller, Agustina
collection PubMed
description BACKGROUND/OBJECTIVES: Central nervous system (CNS) germ cell tumors (GCTs) represent 3% of primary paediatric brain tumours in occident. They can be divided into major groups including germinomas and nongerminomatous GCTs (NGGCTs). The aim is to describe demographic characteristics, Event Free Survival (EFS) and Overall Survival (OS) in patients with GCTs treated at Oncology Unit of Garrahan Hospital (HG). DESIGN/METHODS: Retrospective analysis of patients with GCTs admitted between September 1(st),2000 to September 1(st),2019. Variables analysed: age, localization, treatment, relapse and death. Patients were treated per SIOP-CNSGCTs protocol. For statically analysis SPSS (IBM), for EFS/OS Kaplan-Meyer, Long-rank for significance. RESULTS: Fifty-seven patients were included, comprising 38 Germinomas and 19 NGGCTS. Median age was 146 months (range 11–228). Primary site in localized Germinomas were pineal (16p), suprasellar (7p) and bifocal (7p). Five-year EFS and OS of 100% and 88.5%, respectively. Four patients presented metastatic disease, with an EFS and OS of 60.9% and 66.6%. Tumor site in localized NGGCT were pineal(8p) and suprasellar(5p). Five-year EFS was 81.8% and OS was 80.2%. No patients presented metastatic disease. All patients with high-risk tumor markers at diagnosis relapsed. No significative differences were found in OS neither EFS between groups (Germinomas OS5y 90% vs NGGCTs 74.6%p=0.19[CI95%0.0786–1.689]), (Germinomas EFS5y 78.9% vs NGGCTs5y 81.8%p=0.85[CI95%0.3046–4.230). Global OS and EFS5y was 83% and 72.9%. CONCLUSION: OS of our cohort is lower than what has been shown in current literature. This result may be related to the lack of resources and lower social economic status in our population.
format Online
Article
Text
id pubmed-7715554
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-77155542020-12-09 GCT-71. SIOP STRATEGY TREATMENT FOR CENTRAL NERVOUS SYSTEM GERM CELL TUMORS IN A MIDDLE INCOME COUNTRY Oller, Agustina Sampor, Claudia Baroni, Lorena Freytes, Candela Ponce, Nicolas Fernandez Villanueva, Gabriela Alderete, Daniel Neuro Oncol Germ Cell Tumors BACKGROUND/OBJECTIVES: Central nervous system (CNS) germ cell tumors (GCTs) represent 3% of primary paediatric brain tumours in occident. They can be divided into major groups including germinomas and nongerminomatous GCTs (NGGCTs). The aim is to describe demographic characteristics, Event Free Survival (EFS) and Overall Survival (OS) in patients with GCTs treated at Oncology Unit of Garrahan Hospital (HG). DESIGN/METHODS: Retrospective analysis of patients with GCTs admitted between September 1(st),2000 to September 1(st),2019. Variables analysed: age, localization, treatment, relapse and death. Patients were treated per SIOP-CNSGCTs protocol. For statically analysis SPSS (IBM), for EFS/OS Kaplan-Meyer, Long-rank for significance. RESULTS: Fifty-seven patients were included, comprising 38 Germinomas and 19 NGGCTS. Median age was 146 months (range 11–228). Primary site in localized Germinomas were pineal (16p), suprasellar (7p) and bifocal (7p). Five-year EFS and OS of 100% and 88.5%, respectively. Four patients presented metastatic disease, with an EFS and OS of 60.9% and 66.6%. Tumor site in localized NGGCT were pineal(8p) and suprasellar(5p). Five-year EFS was 81.8% and OS was 80.2%. No patients presented metastatic disease. All patients with high-risk tumor markers at diagnosis relapsed. No significative differences were found in OS neither EFS between groups (Germinomas OS5y 90% vs NGGCTs 74.6%p=0.19[CI95%0.0786–1.689]), (Germinomas EFS5y 78.9% vs NGGCTs5y 81.8%p=0.85[CI95%0.3046–4.230). Global OS and EFS5y was 83% and 72.9%. CONCLUSION: OS of our cohort is lower than what has been shown in current literature. This result may be related to the lack of resources and lower social economic status in our population. Oxford University Press 2020-12-04 /pmc/articles/PMC7715554/ http://dx.doi.org/10.1093/neuonc/noaa222.287 Text en © The Author(s) 2020. Published by Oxford University Press on behalf of the Society for Neuro-Oncology. http://creativecommons.org/licenses/by-nc/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited. For commercial re-use, please contact journals.permissions@oup.com
spellingShingle Germ Cell Tumors
Oller, Agustina
Sampor, Claudia
Baroni, Lorena
Freytes, Candela
Ponce, Nicolas Fernandez
Villanueva, Gabriela
Alderete, Daniel
GCT-71. SIOP STRATEGY TREATMENT FOR CENTRAL NERVOUS SYSTEM GERM CELL TUMORS IN A MIDDLE INCOME COUNTRY
title GCT-71. SIOP STRATEGY TREATMENT FOR CENTRAL NERVOUS SYSTEM GERM CELL TUMORS IN A MIDDLE INCOME COUNTRY
title_full GCT-71. SIOP STRATEGY TREATMENT FOR CENTRAL NERVOUS SYSTEM GERM CELL TUMORS IN A MIDDLE INCOME COUNTRY
title_fullStr GCT-71. SIOP STRATEGY TREATMENT FOR CENTRAL NERVOUS SYSTEM GERM CELL TUMORS IN A MIDDLE INCOME COUNTRY
title_full_unstemmed GCT-71. SIOP STRATEGY TREATMENT FOR CENTRAL NERVOUS SYSTEM GERM CELL TUMORS IN A MIDDLE INCOME COUNTRY
title_short GCT-71. SIOP STRATEGY TREATMENT FOR CENTRAL NERVOUS SYSTEM GERM CELL TUMORS IN A MIDDLE INCOME COUNTRY
title_sort gct-71. siop strategy treatment for central nervous system germ cell tumors in a middle income country
topic Germ Cell Tumors
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7715554/
http://dx.doi.org/10.1093/neuonc/noaa222.287
work_keys_str_mv AT olleragustina gct71siopstrategytreatmentforcentralnervoussystemgermcelltumorsinamiddleincomecountry
AT samporclaudia gct71siopstrategytreatmentforcentralnervoussystemgermcelltumorsinamiddleincomecountry
AT baronilorena gct71siopstrategytreatmentforcentralnervoussystemgermcelltumorsinamiddleincomecountry
AT freytescandela gct71siopstrategytreatmentforcentralnervoussystemgermcelltumorsinamiddleincomecountry
AT poncenicolasfernandez gct71siopstrategytreatmentforcentralnervoussystemgermcelltumorsinamiddleincomecountry
AT villanuevagabriela gct71siopstrategytreatmentforcentralnervoussystemgermcelltumorsinamiddleincomecountry
AT alderetedaniel gct71siopstrategytreatmentforcentralnervoussystemgermcelltumorsinamiddleincomecountry